Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:II-158-II-163
doi: 10.1161/01.CIR.0000138222.43197.1e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonnet, D.
Right arrow Articles by von Segesser, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonnet, D.
Right arrow Articles by von Segesser, L. K.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Congenital Heart Defects
*Palliative Care
*Pulmonary Hypertension

(Circulation. 2004;110:II-158 – II-163.)
© 2004 American Heart Association, Inc.


Surgery for Congenital Heart Disease

Early Clinical Results of the Telemetric Adjustable Pulmonary Artery Banding FloWatch-PAB

Damien Bonnet, MD; Antonio F. Corno, MD; Daniel Sidi, MD; Nicole Sekarski, MD; Maurice Beghetti, MD; Ingram Schulze-Neick, MD; Margrit Fasnacht, MD; Emmanuel Le Bret, MD; Afksendyios Kalangos, MD; Pascal R. Vouhé, MD; Ludwig K. von Segesser, MD

From the Pediatric Cardiology (D.B., D.S., E.L., P.R.V.), Hôpital Necker Enfants Malades, Paris, France; Centre Hospitalier Universitaire Vaudois (A.F.C., N.S., L.K.V), Lausanne, Switzerland; Cardiology Unit (M.B., A.K.), Hôpital des Enfants, Department of Paediatrics (I.S.N), Geneva, Switzerland; Abteilung fur Angeborene Herzfehler, Deutsches Herzzentrum Berlin, Berlin, Germany; Oberärztin Kardiologie Universitätskinderklinik (M.F.), Zürich, Switzerland.

Correspondence to Damien Bonnet, Cardiologie Pédiatrique, Hôpital Necker Enfants Malades AP-HP, 149, rue de Sèvres 75743 Paris cedex 15, France, EU. E-mail damien.bonnet{at}nck.ap-hop-paris.fr

Background— Adjustment of pulmonary artery banding (PAB) may be a challenging procedure in complex congenital heart defects. Whatever the technique used, subsequent re-operations are frequently needed to control the pulmonary blood flow or pressures.

Objective— To report the efficacy of a new telemetric adjustable PAB (FloWatch-PAB) operated with the help of an external control unit that transmits to the implant energy and commands to further narrow or release the pulmonary artery using radiofrequency waves.

Methods and Results— In a multicenter, prospective, nonrandomized, single-arm clinical investigation, 13 children (median age, 4.5 months; range, 6 days to 11 years; median weight, 4.2 kg; range, 3.1 to 27kg) underwent implantation of the FloWatch-PAB through median sternotomy in 8 and left thoracotomy in 5. The diagnosis was multiple ventricular septal (VSD) defects with complex anatomy in 3, single ventricle without pulmonary stenosis in 2, VSD with elevated pulmonary vascular resistance (PVR) in 2, atrio-ventricular canal (AVC) with elevated pulmonary vascular resistance in 1, AVC with diminutive right ventricle in 1, complex transposition of the great arteries in 3, and pulmonary atresia with complex pulmonary arteries anatomy in 1. All patients had normosystemic systolic pulmonary artery pressure. Additional procedures were performed in 7: atrial septectomy in 2, double aortic arch division in 1, patent ductus arteriosus ligation in 2, and coarctation repair in 2. There were no early or late deaths or device-related complications in a mean follow-up of 24 weeks (range, 18 to 42 weeks). A mean of 5.8 telemetric regulations per patient using the FloWatch-PAB were required to adjust the tightening of the PAB to the clinical needs (narrowing 74%, releasing 26%). At last follow-up, systolic pulmonary artery pressure was within normal range in all patients but 1. Systemic oxygen saturation demonstrated optimal regulation of the pulmonary blood flow in all according to each specific defect. Four patients were successfully corrected (VSD closure, AVSD repair, and 2 arterial switches with VSD closure). The device was easily removed and the pulmonary artery re-expanded spontaneously.

Conclusion— This new device is safe and allows optimal adjustment of PAB in complex heart defects. In children requiring PAB, the use of this technology can obviate the need for early re-operations and appears to be a valuable option in the panel of surgical alternatives for selected infants.


Key Words: congenital heart defects • pulmonary artery banding • adjustable device